These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16507390)
1. Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression. Chan CM; Ma BB; Wong SC; Chan AT Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S268-71. PubMed ID: 16507390 [TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity. Li WW; Long GX; Liu DB; Mei Q; Wang JF; Hu GY; Jiang JZ; Sun W; Gan L; Hu GQ Pharmazie; 2014 Feb; 69(2):132-7. PubMed ID: 24640603 [TBL] [Abstract][Full Text] [Related]
3. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Liu DB; Hu GY; Long GX; Qiu H; Mei Q; Hu GQ Acta Pharmacol Sin; 2012 May; 33(5):682-90. PubMed ID: 22504904 [TBL] [Abstract][Full Text] [Related]
4. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871 [TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines. Liu DB; Long GX; Mei Q; Wang JF; Hu GY; Gan L; Li WW; Sun W; Liu SF; Jiang JZ; Hu GQ Pharmazie; 2014 May; 69(5):358-61. PubMed ID: 24855827 [TBL] [Abstract][Full Text] [Related]
6. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis. Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156 [TBL] [Abstract][Full Text] [Related]
8. [Influence of celecoxib on invasiveness of human high-metastatic nasopharyngeal carcinoma cell line CNE-2Z]. Luo WR; Li LX; Li SY; Jiang HG; Chen XY Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Nov; 45(11):941-5. PubMed ID: 21215211 [TBL] [Abstract][Full Text] [Related]
9. The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway. Sareddy GR; Geeviman K; Ramulu C; Babu PP J Neurooncol; 2012 Jan; 106(1):99-109. PubMed ID: 21847707 [TBL] [Abstract][Full Text] [Related]
10. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma. Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838 [TBL] [Abstract][Full Text] [Related]
11. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s). Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143 [TBL] [Abstract][Full Text] [Related]
12. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
14. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53. Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625 [TBL] [Abstract][Full Text] [Related]
15. Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells. Liu H; Huang P; Xu X; Liu J; Guo C Dig Dis Sci; 2009 Jul; 54(7):1418-24. PubMed ID: 18923901 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo. Xu XF; Xie CG; Wang XP; Liu J; Yu YC; Hu HL; Guo CY Tohoku J Exp Med; 2008 Jun; 215(2):149-57. PubMed ID: 18577844 [TBL] [Abstract][Full Text] [Related]
17. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
18. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism]. Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281 [TBL] [Abstract][Full Text] [Related]
19. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477 [TBL] [Abstract][Full Text] [Related]
20. Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma. Abrahão AC; Giudice FS; Sperandio FF; Pinto Junior Ddos S J Oral Pathol Med; 2013 Nov; 42(10):793-8. PubMed ID: 23679684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]